Picton Mahoney Asset Management’s Immunogen Inc IMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding IMGN
Picton Mahoney Asset Management's IMGN Position: Q1 2024 in Review
Picton Mahoney Asset Management sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 500,000 shares — an estimated $14.8M sold.
Picton Mahoney Asset Management first reported a position in IMGN in Q4 2023 and held it in 1 quarter. The position peaked at $14.8M in Q4 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.
- Picton Mahoney Asset Management reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
- Picton Mahoney Asset Management sold 500,000 Immunogen Inc shares in Q1 2024, an estimated $14.8M.
- Picton Mahoney Asset Management first reported a position in Immunogen Inc in Q4 2023 and held it in 1 quarter.
- Picton Mahoney Asset Management's Immunogen Inc position peaked at $14.8M in Q4 2023.
- 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.
Based on Picton Mahoney Asset Management's 13F filing for Q1 2024, filed 9 May 2024.